These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35721163)

  • 1. Molecular Mechanism of Anti-Colorectal Cancer Effect of
    Wu Z; Yin B; You F
    Front Pharmacol; 2022; 13():820474. PubMed ID: 35721163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hedyotis diffusa Willd suppresses metastasis in 5‑fluorouracil‑resistant colorectal cancer cells by regulating the TGF‑β signaling pathway.
    Lai Z; Yan Z; Chen W; Peng J; Feng J; Li Q; Jin Y; Lin J
    Mol Med Rep; 2017 Nov; 16(5):7752-7758. PubMed ID: 28944846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hedyotis diffusa Willd extract suppresses Sonic hedgehog signaling leading to the inhibition of colorectal cancer angiogenesis.
    Lin J; Wei L; Shen A; Cai Q; Xu W; Li H; Zhan Y; Hong Z; Peng J
    Int J Oncol; 2013 Feb; 42(2):651-6. PubMed ID: 23291612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hedyotis diffusa Willd inhibits proliferation and induces apoptosis of 5‑FU resistant colorectal cancer cells by regulating the PI3K/AKT signaling pathway.
    Li Q; Lai Z; Yan Z; Peng J; Jin Y; Wei L; Lin J
    Mol Med Rep; 2018 Jan; 17(1):358-365. PubMed ID: 29115462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the Multi-Target Pharmacological Mechanism of
    Song Y; Wang H; Pan Y; Liu T
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31600936
    [No Abstract]   [Full Text] [Related]  

  • 6. A Network Pharmacology Approach to Uncover the Multiple Mechanisms of
    Liu X; Wu J; Zhang D; Wang K; Duan X; Zhang X
    Evid Based Complement Alternat Med; 2018; 2018():6517034. PubMed ID: 29619072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Targets and Mechanisms of Hedyotis diffusa Willd. for Esophageal Adenocarcinoma Treatment Based on Network Pharmacology and Weighted Gene Co-expression Network Analysis.
    Zhuang Y; Sun YG; Wang CG; Zhang Q; Che C; Shao F
    Curr Drug Targets; 2024; 25(6):431-443. PubMed ID: 38213161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-tumor effect and bioactive phytochemicals of Hedyotis diffusa willd on ovarian cancer cells.
    Zhang L; Zhang J; Qi B; Jiang G; Liu J; Zhang P; Ma Y; Li W
    J Ethnopharmacol; 2016 Nov; 192():132-139. PubMed ID: 27426510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hedyotis diffusa Willd. inhibits VEGF‑C‑mediated lymphangiogenesis in colorectal cancer via multiple signaling pathways.
    Li H; Lai Z; Yang H; Peng J; Chen Y; Lin J
    Oncol Rep; 2019 Sep; 42(3):1225-1236. PubMed ID: 31322263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hedyotis diffusa Willd extract inhibits HT-29 cell proliferation via cell cycle arrest.
    Lin M; Lin J; Wei L; Xu W; Hong Z; Cai Q; Peng J; Zhu D
    Exp Ther Med; 2012 Aug; 4(2):307-310. PubMed ID: 23139718
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Feng J; Jin Y; Peng J; Wei L; Cai Q; Yan Z; Lai Z; Lin J
    Oncol Lett; 2017 Dec; 14(6):8197-8205. PubMed ID: 29344262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloroform extract of
    Yan Z; Feng J; Peng J; Lai Z; Zhang L; Jin Y; Yang H; Chen W; Lin J
    Oncol Lett; 2017 Dec; 14(6):7923-7930. PubMed ID: 29344237
    [No Abstract]   [Full Text] [Related]  

  • 13. Systems pharmacology uncover the mechanism of anti-non-small cell lung cancer for Hedyotis diffusa Willd.
    Su X; Li Y; Jiang M; Zhu J; Zheng C; Chen X; Zhou J; Li Y; Xiao W; Wang Y
    Biomed Pharmacother; 2019 Jan; 109():969-984. PubMed ID: 30551551
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Huang L; Xu H; Wu T; Li G
    Evid Based Complement Alternat Med; 2021; 2021():5210152. PubMed ID: 34527062
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Li Q; Wang X; Shen A; Zhang Y; Chen Y; Sferra TJ; Lin J; Peng J
    Exp Ther Med; 2015 Nov; 10(5):1845-1850. PubMed ID: 26640560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of
    Sun G; Wei L; Feng J; Lin J; Peng J
    Oncol Lett; 2016 Jun; 11(6):3875-3881. PubMed ID: 27313710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedyotis diffusa Willd extract inhibits the growth of human glioblastoma cells by inducing mitochondrial apoptosis via AKT/ERK pathways.
    Zhang Y; Xie RF; Xiao QG; Li R; Shen XL; Zhu XG
    J Ethnopharmacol; 2014 Dec; 158 Pt A():404-11. PubMed ID: 25456437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer Effects of 1,3-Dihydroxy-2-Methylanthraquinone and the Ethyl Acetate Fraction of Hedyotis Diffusa Willd against HepG2 Carcinoma Cells Mediated via Apoptosis.
    Li YL; Zhang J; Min D; Hongyan Z; Lin N; Li QS
    PLoS One; 2016; 11(4):e0151502. PubMed ID: 27064569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor potential of Hedyotis diffusa Willd: A systematic review of bioactive constituents and underlying molecular mechanisms.
    Han X; Zhang X; Wang Q; Wang L; Yu S
    Biomed Pharmacother; 2020 Oct; 130():110735. PubMed ID: 34321173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hedyotis Diffusa Willd extract induces apoptosis via activation of the mitochondrion-dependent pathway in human colon carcinoma cells.
    Lin J; Chen Y; Wei L; Chen X; Xu W; Hong Z; Sferra TJ; Peng J
    Int J Oncol; 2010 Nov; 37(5):1331-8. PubMed ID: 20878081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.